CP8-9 NF-κB Function Inhibitor, DHMEQ as a Treatment Option for Advanced Urological Cancer

Japanese Journal of Urology - Japan
doi 10.5980/jpnjurol.95.163_2
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Japanese Urological Association

Related search

NF‑κB Inhibitor DHMEQ Inhibits Titanium Dioxide Nanoparticle‑induced Interleukin‑1β Production: Inhibition of the PM2.5‑induced Inflammation Model

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

NF-κB as Potential Target in the Treatment of Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2012English

IκBβ, but Not IκBα, Functions as a Classical Cytoplasmic Inhibitor of NF-κB Dimers by Masking Both NF-κB Nuclear Localization Sequences in Resting Cells

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2001English

Spinal Cord Stimulation as a Treatment Option for Intractable Neuropathic Cancer Pain

Clinical Medicine and Research
MedicineHome CareCommunity
2008English

Brachytherapy as a Treatment Option for Prostate Cancer: Overview and Nursing Considerations

Baylor University Medical Center Proceedings
Medicine
2000English

Urinary Trypsin Inhibitor as a Therapeutic Option for Inflammatory Disorders

OA Biotechnology
2013English

New Insights Into NF-κB Regulation and Function

Trends in Immunology
AllergyImmunology
2008English

Guided Imagery as a Treatment Option for Fatigue

Journal of Holistic Nursing
Nursing
2011English

A Nucleosomal Function for IκB Kinase-Α in NF-κB-dependent Gene Expression

Nature
Multidisciplinary
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy